Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

BACKGROUND: Immune modulating therapies are associated with an increased risk of infections and malignancies. This is of particular concern in elderly inflammatory bowel disease patients. This study aims to compare the safety and efficacy of vedolizumab between young and elderly inflammatory bowel d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Cohen, Nathaniel Aviv, Plevris, Nikolas, Kopylov, Uri, Grinman, Anna, Ungar, Bella, Yanai, Henit, Leibovitzh, Haim, Isakov, Naomi Fliss, Hirsch, Ayal, Ritter, Einat, Ron, Yulia, Shitrit, Ariella Bar-Gil, Goldin, Eran, Dotan, Iris, Horin, Shomron Ben, Lees, Charlie W, Maharshak, Nitsan
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724539/
https://ncbi.nlm.nih.gov/pubmed/32807038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620951400
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados